Cargando…
Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1
BACKGROUND: Sodium butyrate, a histone deacetylase inhibitor, has emerged as a promising anticancer drug for multiple cancers. Recent studies have indicated that sodium butyrate could inhibit the progression of prostate cancer; however, the exact mechanism is still unclear. The aim of this study was...
Autores principales: | Mu, Dawei, Gao, Zhuo, Guo, Heqing, Zhou, Gaobiao, Sun, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781143/ https://www.ncbi.nlm.nih.gov/pubmed/24086397 http://dx.doi.org/10.1371/journal.pone.0074922 |
Ejemplares similares
-
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer
por: Kuefer, R, et al.
Publicado: (2004) -
Anthocyanin Induces Apoptosis of DU-145 Cells In Vitro and Inhibits Xenograft Growth of Prostate Cancer
por: Ha, U-Syn, et al.
Publicado: (2015) -
Retinoic Acid Induces Apoptosis of Prostate Cancer DU145 Cells through Cdk5 Overactivation
por: Chen, Mei-Chih, et al.
Publicado: (2012) -
Glucosamine Enhances TRAIL-Induced Apoptosis in the Prostate Cancer Cell Line DU145
por: Sun, Chao, et al.
Publicado: (2019) -
SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway
por: Choi, Yu-Jeong, et al.
Publicado: (2016)